loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 84897 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Chartwell Pharmaceuticals llc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE (1)

    filter

    01 CHARTWELL RX (1)

    filter

    01 TABLET;ORAL (1)

    filter

    01 25MG;15MG;0.1MG (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Hydralazine Hydrochloride; Hydrochlorothiazide; Reserpine

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET;ORAL
    25MG;15MG;0.1MG
    CAM-AP-ES
    USA
    84897
    1982-01-01
    DISCN
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for CTD TGA MCC DOSSIER APPLICATION 84897

    Looking for CTD TGA MCC DOSSIER APPLICATION 84897 1

    19

    Chartwell Pharmaceuticals llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE, with a corresponding application number 84897 and regulatory information .

    proudly manufactured in the

    approval since 1982-01-01

    Chartwell Pharmaceuticals llc's CAM-AP-ES TABLET;ORAL, medication with 25MG;15MG;0.1MG of HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE.

    Post Enquiry
    POST ENQUIRY